Jean-Marc Bellemin insider trades

Open-market stock purchases and sales by Jean-Marc Bellemin, Chief Financial Officer at Iovance Biotherapeutics, Inc, from SEC Form 4 filings since Feb 13, 2019.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • IOVA Iovance Biotherapeutics, Inc: other filings, last Jun 2, 2025
  • GRTS Gritstone Oncology, Inc: other filings, last Feb 25, 2020

Get free alerts when Jean-Marc Bellemin files a new trade →